Department of Pediatrics, Dajia Lee's Hospital, Lee's Medical Corporation, Taichung, Taiwan.
Pediatr Neonatol. 2011 Feb;52(1):5-10. doi: 10.1016/j.pedneo.2010.12.006. Epub 2011 Feb 18.
Airway remodeling refers to the structural changes in the airways of asthma. Caveolin-1 reduces cell growth and negatively regulates smooth muscle cell proliferation. The aim was to investigate lung caveolin-1 status in a murine model of acute allergic airway disease.
Six- to eight-week-old female BALB/c mice were sensitized by intraperitoneal injections of phosphate-buffered saline or ovalbumin (OVA) and aluminium hydroxide on Days 0 and 14, challenged with aerosolized saline or OVA (1%) on Days 21-25, 28-32, and 35. The mice were killed 1 day after the last OVA/saline challenge. Serum OVA-specific immunoglobulin E (IgE) was measured by enzyme-linked immunosorbent assay. Peribronchial inflammation was quantified by morphometric analysis. Lung caveolin-1 and Type I collagen mRNA expression was determined by real-time reverse-transcription polymerase chain reaction. Total lung collagen was measured using Sircol Assay Kit.
Serum OVA-specific IgE levels were significantly elevated in OVA-challenged mice when compared with saline-challenged mice. Percentage of inflammatory cells in the bronchoalveolar lavage was significantly higher in the OVA-challenged animals. The animals' lungs that were sensitized and challenged with OVA contained large numbers of inflammatory cells concentrated near the airways and in the perivascular areas. The thickness of the bronchial epithelial layer and smooth muscle layer and the numbers of total inflammatory cells and eosinophils significantly increased in OVA-challenged mice. Caveolin-1 mRNA expression significantly decreased and Type I collagen mRNA expression significantly increased in the lung tissue of OVA-challenged mice.
These results suggest that caveolin-1 seems to be involved in the pathogenesis of airway remodeling of acute allergic airway disease.
气道重塑是指哮喘患者气道的结构改变。窖蛋白-1 可抑制细胞生长并负向调节平滑肌细胞增殖。本研究旨在探讨急性变应性气道疾病小鼠模型中肺窖蛋白-1 的状态。
6-8 周龄雌性 BALB/c 小鼠分别用磷酸盐缓冲液或卵清蛋白(OVA)和氢氧化铝腹腔注射致敏,于第 0 天和第 14 天,第 21-25 天、第 28-32 天及第 35 天用雾化生理盐水或 OVA(1%)激发。末次 OVA/生理盐水激发后 1 天处死小鼠。酶联免疫吸附试验检测血清 OVA 特异性免疫球蛋白 E(IgE)。形态计量学分析检测支气管周围炎症。实时逆转录聚合酶链反应检测肺窖蛋白-1 和 I 型胶原 mRNA 表达。使用 Sircol 试剂盒测定总肺胶原。
OVA 激发组小鼠血清 OVA 特异性 IgE 水平明显高于生理盐水激发组。OVA 激发组小鼠支气管肺泡灌洗液中炎症细胞百分比明显升高。OVA 致敏和激发的小鼠肺组织中大量炎症细胞聚集在气道周围和血管周围。OVA 激发组小鼠的支气管上皮层和平滑肌层厚度以及总炎症细胞和嗜酸性粒细胞数量均显著增加。OVA 激发组小鼠肺组织中窖蛋白-1 mRNA 表达明显降低,I 型胶原 mRNA 表达明显增加。
这些结果提示窖蛋白-1 似乎参与了急性变应性气道疾病气道重塑的发病机制。